Home Advanced Inhalation Therapies

Advanced Inhalation Therapies

In operation
Post-IPO Round
Nitric Oxide (NO) Formula Developer
Basic
Enterprise Profile

Basic Information

Advanced Inhalation Technology (AIT) is an emerging Israeli biotechnology company dedicated to the development and commercialization of nitric oxide (NO) formulations for the treatment of pulmonary infections. AIT's pipeline includes treatments for bronchiolitis (primarily RSV - Respiratory Syncytial Virus), cystic fibrosis (CF), pneumonia, asthma, and influenza.
Advanced Inhalation Therapies Ltd.
Israel
less than 15 people
January 01, 2011
racheli@ait-pharm.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology Biotechnology
Application Scenarios
Innovative Drugs